نتائج البحث - "Mamidi, Rao N. V. S."

1

دورية أكاديمية

Prediction of the drug–drug interaction potential of the α1‐acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib

المؤلفون: De Zwart, Loeckie, Snoeys, Jan, Jacobs, Frank, Li, Lilian Y., Poggesi, Italo, Verboven, Peter, Goris, Ivo, Scheers, Ellen, Wynant, Inneke, Monshouwer, Mario, Mamidi, Rao N. V. S.

المساهمون: Janssen Research and Development

المصدر: CPT: Pharmacometrics & Systems Pharmacology ; volume 10, issue 9, page 1107-1118 ; ISSN 2163-8306 2163-8306

الإتاحة: https://doi.org/10.1002/psp4.12682Test

View record in BASE

2

دورية أكاديمية

Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE)

المؤلفون: Saad, Fred, Chi, Kim N., Shore, Neal D., Graff, Julie N., Posadas, Edwin M., Lattouf, Jean-Baptiste, Espina, Byron M., Zhu, Eugene, Yu, Alex, Hazra, Anasuya, De Meulder, Marc, Mamidi, Rao N. V. S., Bradic, Branislav, Francis, Peter, Hayreh, Vinny, Rezazadeh Kalebasty, Arash

المساهمون: Janssen Research and Development

المصدر: Cancer Chemotherapy and Pharmacology ; volume 88, issue 1, page 25-37 ; ISSN 0344-5704 1432-0843

مصطلحات موضوعية: Pharmacology (medical), Cancer Research, Pharmacology, Toxicology, Oncology

الإتاحة: https://doi.org/10.1007/s00280-021-04249-7Test

View record in BASE

3

دورية أكاديمية

In vitro and physiologically‐based pharmacokinetic based assessment of drug–drug interaction potential of canagliflozin

المؤلفون: Mamidi, Rao N. V. S., Dallas, Shannon, Sensenhauser, Carlo, Lim, Heng Keang, Scheers, Ellen, Verboven, Peter, Cuyckens, Filip, Leclercq, Laurent, Evans, David C., Kelley, Michael F., Johnson, Mark D., Snoeys, Jan

المصدر: British Journal of Clinical Pharmacology ; volume 83, issue 5, page 1082-1096 ; ISSN 0306-5251 1365-2125

الإتاحة: https://doi.org/10.1111/bcp.13186Test

View record in BASE

4

دورية أكاديمية

Metabolism and disposition in rats, dogs, and humans of erdafitinib, an orally administered potent pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor

المؤلفون: Scheers, Ellen, Borgmans, Carine, Keung, Chi, Bohets, Hilde, Wynant, Inneke, Poggesi, Italo, Cuyckens, Filip, Leclercq, Laurent, Mamidi, Rao N. V. S.

المصدر: Xenobiotica ; volume 51, issue 2, page 177-193 ; ISSN 0049-8254 1366-5928

الإتاحة: https://doi.org/10.1080/00498254.2020.1821123Test

View record in BASE

5

دورية أكاديمية

Effect of Fluconazole and Itraconazole on the Pharmacokinetics of Erdafitinib in Healthy Adults: A Randomized, Open-Label, Drug–Drug Interaction Study

المؤلفون: Poggesi, Italo, Li, Lilian Y., Jiao, James, Hellemans, Peter, Rasschaert, Freya, de Zwart, Loeckie, Snoeys, Jan, De Meulder, Marc, Mamidi, Rao N. V. S., Ouellet, Daniele

المساهمون: Janssen Research and Development

المصدر: European Journal of Drug Metabolism and Pharmacokinetics ; volume 45, issue 1, page 101-111 ; ISSN 0378-7966 2107-0180

مصطلحات موضوعية: Pharmacology (medical), Pharmacology

الإتاحة: https://doi.org/10.1007/s13318-019-00581-9Test

View record in BASE

6

دورية أكاديمية

Metabolism and disposition in rats, dogs, and humans of erdafitinib, an orally administered potent pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor.

المؤلفون: Scheers, Ellen, Borgmans, Carine, Keung, Chi, Bohets, Hilde, Wynant, Inneke, Poggesi, Italo, Cuyckens, Filip, Leclercq, Laurent, Mamidi, Rao N. V. S.

المصدر: Xenobiotica; Feb2021, Vol. 51 Issue 2, p177-193, 17p

مصطلحات موضوعية: PROTEIN-tyrosine kinase inhibitors, PSYCHONEUROIMMUNOLOGY, BILE, DOGS, RATS, METABOLISM, HUMAN beings

7

دورية أكاديمية

Effect of Fluconazole and Itraconazole on the Pharmacokinetics of Erdafitinib in Healthy Adults: A Randomized, Open-Label, Drug–Drug Interaction Study.

المؤلفون: Poggesi, Italo, Li, Lilian Y., Jiao, James, Hellemans, Peter, Rasschaert, Freya, de Zwart, Loeckie, Snoeys, Jan, De Meulder, Marc, Mamidi, Rao N. V. S., Ouellet, Daniele

المصدر: European Journal of Drug Metabolism & Pharmacokinetics; Feb2020, Vol. 45 Issue 1, p101-111, 11p

8

دورية أكاديمية

In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humans

المؤلفون: Francke, Stephan, Mamidi, Rao N. V. S., Solanki, Bhavna, Scheers, Ellen, Jadwin, Andrew, Favis, Reyna, Devineni, Damayanthi

المصدر: The Journal of Clinical Pharmacology ; volume 55, issue 9, page 1061-1072 ; ISSN 0091-2700 1552-4604

الإتاحة: https://doi.org/10.1002/jcph.506Test

View record in BASE

9

دورية أكاديمية

Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants

المؤلفون: Devineni, Damayanthi, Manitpisitkul, Prasarn, Murphy, Joseph, Skee, Donna, Wajs, Ewa, Mamidi, Rao N. V. S., Tian, Hong, Vandebosch, An, Wang, Shean‐Sheng, Verhaeghe, Tom, Stieltjes, Hans, Usiskin, Keith

المساهمون: Janssen Research and Development

المصدر: Clinical Pharmacology in Drug Development ; volume 4, issue 3, page 226-236 ; ISSN 2160-763X 2160-7648

الإتاحة: https://doi.org/10.1002/cpdd.166Test

View record in BASE

10

دورية أكاديمية

Successful Integration of Nonclinical and Clinical Findings in Interpreting the Clinical Relevance of Rodent Neoplasia with a New Chemical Entity

المؤلفون: Ways, Kirk, Johnson, Mark D., Mamidi, Rao N. V. S., Proctor, James, De Jonghe, Sandra, Louden, Calvert

المصدر: Toxicologic Pathology ; volume 43, issue 1, page 48-56 ; ISSN 0192-6233 1533-1601

مصطلحات موضوعية: Cell Biology, Toxicology, Molecular Biology, Pathology and Forensic Medicine

الإتاحة: https://doi.org/10.1177/0192623314557179Test

View record in BASE

تنقيح النتائج